Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$21,490.78
% of Total Estimate Gain
9.94%

S&P MidCap 400 Pure Value Fund's The Chemours Co Holding Summary

As of 2025-03-31, RYDEX SERIES FUNDS held - shares of The Chemours Co(CC), totaling N/A. This investment constitutes 0% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0% of the outstanding The Chemours Co(CC) stock.

The initial trade took place in 2019Q4. And since then S&P MidCap 400 Pure Value Fund has made 4 purchases of CC, at an average price of $18.99, for a total of 11,389.00 shares. In addition, there have been 5 sales at an average price of $20.88 for 11,389.00 shares. Based on historical transaction data and CC's current price of $13.67, S&P MidCap 400 Pure Value Fund's estimated gain on his CC holdings is $21,490.78, reflecting a 9.94% gain to date.

S&P MidCap 400 Pure Value Fund CC ($13.67) Holding Chart

S&P MidCap 400 Pure Value Fund CC ($13.67) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1